Literature DB >> 26482750

Management of Hypertension in Children and Adolescents.

Joshua Samuels1,2, Cynthia Bell3, Joyce Samuel4,5, Rita Swinford6,7.   

Abstract

Hypertension in children and adolescents is becoming a greater problem in the developed world. Although traditionally thought of as usually secondary to renal, vascular, or endocrine causes, primary hypertension is becoming the most common form seen in childhood. This changing epidemiology is related to the recent obesity epidemic. The evaluation of high blood pressure in children is more involved than in adults and is aimed both at identifying secondary causes and to identify other co-morbidities of cardiovascular risk. Treatment of hypertension in childhood and adolescence is aimed at reducing cardiovascular risk. While there are a growing number of antihypertensive agents with FDA labeling for children, there remain far fewer options than for adults. This paper reviews the epidemiology, definitions, evaluations, and management of elevated blood pressure in children and adolescents.

Entities:  

Keywords:  Adolescent; Blood pressure; Hypertension; Pediatric; Pre-hypertension

Mesh:

Substances:

Year:  2015        PMID: 26482750     DOI: 10.1007/s11886-015-0661-1

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  54 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  White coat hypertension in childhood: evidence for end-organ effect.

Authors:  Rae-Ellen W Kavey; Daniel A Kveselis; Nader Atallah; Frank C Smith
Journal:  J Pediatr       Date:  2007-05       Impact factor: 4.406

3.  High blood pressure trends in children and adolescents in national surveys, 1963 to 2002.

Authors:  Rebecca Din-Dzietham; Yong Liu; Marie-Vero Bielo; Falah Shamsa
Journal:  Circulation       Date:  2007-09-10       Impact factor: 29.690

4.  Severe Obesity in Adolescents and Young Adults Is Associated With Subclinical Cardiac and Vascular Changes.

Authors:  Amy S Shah; Lawrence M Dolan; Philip R Khoury; Zhiqan Gao; Thomas R Kimball; Elaine M Urbina
Journal:  J Clin Endocrinol Metab       Date:  2015-05-14       Impact factor: 5.958

5.  Childhood obesity, other cardiovascular risk factors, and premature death.

Authors:  Paul W Franks; Robert L Hanson; William C Knowler; Maurice L Sievers; Peter H Bennett; Helen C Looker
Journal:  N Engl J Med       Date:  2010-02-11       Impact factor: 91.245

6.  Carotid intima-media thickness in children with CKD: results from the CKiD study.

Authors:  Tammy M Brady; Michael F Schneider; Joseph T Flynn; Christopher Cox; Joshua Samuels; Jeffrey Saland; Colin T White; Susan Furth; Bradley A Warady; Mark Mitsnefes
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-13       Impact factor: 8.237

Review 7.  Vascular effects of dietary salt.

Authors:  David G Edwards; William B Farquhar
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-01       Impact factor: 2.894

8.  Evaluation of white coat hypertension in children: importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension.

Authors:  J M Sorof; T Poffenbarger; K Franco; R Portman
Journal:  Am J Hypertens       Date:  2001-09       Impact factor: 2.689

9.  White coat hypertension in children with elevated casual blood pressure.

Authors:  J M Sorof; R J Portman
Journal:  J Pediatr       Date:  2000-10       Impact factor: 4.406

10.  Screening children for high blood pressure: where the US Preventive Services Task Force went wrong.

Authors:  Joshua A Samuels; Cynthia Bell; Joseph T Flynn
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-06-17       Impact factor: 3.738

View more
  1 in total

1.  The relationship between hyperthyrotropinemia and metabolic and cardiovascular risk factors in a large group of overweight and obese children and adolescents.

Authors:  G Radetti; G Grugni; F Lupi; N Marazzi; S Longhi; A Fanolla; A Sartorio
Journal:  J Endocrinol Invest       Date:  2017-06-05       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.